Cargando…

Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study

BACKGROUND: Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tebib, Nicolas, Tebib, Nathalie, Paredes, Mauricio, Castro, Rosario, Baggio, Stéphanie, Torrico, Mario Villarroel, Leon, Amilcar Alejandro Flores, Zamorano, Maya Herbas, Chappuis, Francois, Getaz, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903486/
https://www.ncbi.nlm.nih.gov/pubmed/36750775
http://dx.doi.org/10.1186/s12882-023-03074-9
_version_ 1784883480876810240
author Tebib, Nicolas
Tebib, Nathalie
Paredes, Mauricio
Castro, Rosario
Baggio, Stéphanie
Torrico, Mario Villarroel
Leon, Amilcar Alejandro Flores
Zamorano, Maya Herbas
Chappuis, Francois
Getaz, Laurent
author_facet Tebib, Nicolas
Tebib, Nathalie
Paredes, Mauricio
Castro, Rosario
Baggio, Stéphanie
Torrico, Mario Villarroel
Leon, Amilcar Alejandro Flores
Zamorano, Maya Herbas
Chappuis, Francois
Getaz, Laurent
author_sort Tebib, Nicolas
collection PubMed
description BACKGROUND: Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication. In this study, we aimed to estimate the prevalence and associated risk factors of S. stercoralis infection in patients on dialysis in Cochabamba, Bolivia. METHODS: A cross-sectional study was carried out among patients undergoing haemodialysis in Cochabamba (elevation 2,500 m, temperate climate), collecting information on socio-demographic, lifestyle, and clinical variables, and using one coproparasitological technique (the modified Baermann technique) and one serological (ELISA) test for S.stercoralis diagnosis. RESULTS: In total, 149 patients participated in the study (mean age = 51.4 years, 48.3% male). End-stage renal disease was predominantly (59%) of hypertensive and/or diabetic origin. The positive serological prevalence was 18.8% (95% CI: 13.3%–25.9%). Based on the sensitivity and specificity of the ELISA test, the estimate of the actual prevalence was 15.1% (95% CI: 9.4%–20.7%). Stool samples of 105 patients (70.5%) showed a coproparasitological prevalence of 1.9% (95% CI: 0.52%–6.68%). No potential risk factors were significantly associated with S. stercoralis infection. CONCLUSIONS: We found a high seroprevalence of S. stercoralis in Bolivian patients undergoing haemodialysis in Cochabamba. We recommend presumptive antiparasitic treatment at regular intervals to avoid the potentially fatal complications of severe strongyloidiasis.
format Online
Article
Text
id pubmed-9903486
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99034862023-02-08 Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study Tebib, Nicolas Tebib, Nathalie Paredes, Mauricio Castro, Rosario Baggio, Stéphanie Torrico, Mario Villarroel Leon, Amilcar Alejandro Flores Zamorano, Maya Herbas Chappuis, Francois Getaz, Laurent BMC Nephrol Research BACKGROUND: Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication. In this study, we aimed to estimate the prevalence and associated risk factors of S. stercoralis infection in patients on dialysis in Cochabamba, Bolivia. METHODS: A cross-sectional study was carried out among patients undergoing haemodialysis in Cochabamba (elevation 2,500 m, temperate climate), collecting information on socio-demographic, lifestyle, and clinical variables, and using one coproparasitological technique (the modified Baermann technique) and one serological (ELISA) test for S.stercoralis diagnosis. RESULTS: In total, 149 patients participated in the study (mean age = 51.4 years, 48.3% male). End-stage renal disease was predominantly (59%) of hypertensive and/or diabetic origin. The positive serological prevalence was 18.8% (95% CI: 13.3%–25.9%). Based on the sensitivity and specificity of the ELISA test, the estimate of the actual prevalence was 15.1% (95% CI: 9.4%–20.7%). Stool samples of 105 patients (70.5%) showed a coproparasitological prevalence of 1.9% (95% CI: 0.52%–6.68%). No potential risk factors were significantly associated with S. stercoralis infection. CONCLUSIONS: We found a high seroprevalence of S. stercoralis in Bolivian patients undergoing haemodialysis in Cochabamba. We recommend presumptive antiparasitic treatment at regular intervals to avoid the potentially fatal complications of severe strongyloidiasis. BioMed Central 2023-02-07 /pmc/articles/PMC9903486/ /pubmed/36750775 http://dx.doi.org/10.1186/s12882-023-03074-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tebib, Nicolas
Tebib, Nathalie
Paredes, Mauricio
Castro, Rosario
Baggio, Stéphanie
Torrico, Mario Villarroel
Leon, Amilcar Alejandro Flores
Zamorano, Maya Herbas
Chappuis, Francois
Getaz, Laurent
Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study
title Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study
title_full Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study
title_fullStr Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study
title_full_unstemmed Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study
title_short Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study
title_sort prevalence and risk factors of strongyloides stercoralis in haemodialysis in cochabamba, bolivia: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903486/
https://www.ncbi.nlm.nih.gov/pubmed/36750775
http://dx.doi.org/10.1186/s12882-023-03074-9
work_keys_str_mv AT tebibnicolas prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT tebibnathalie prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT paredesmauricio prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT castrorosario prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT baggiostephanie prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT torricomariovillarroel prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT leonamilcaralejandroflores prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT zamoranomayaherbas prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT chappuisfrancois prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy
AT getazlaurent prevalenceandriskfactorsofstrongyloidesstercoralisinhaemodialysisincochabambaboliviaacrosssectionalstudy